Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-26
1993-12-28
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514423, 548517, 548537, A61K 3140, C07D40506
Patent
active
052739953
ABSTRACT:
[R-(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-((1-methylethyl)- 3-phenyl-4-[(phenylamino)-carbonyl]-1H-pyrrole-1-heptanoic acid or (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl-N,4-diphenyl-1-[2-(tetrahyd ro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide; and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4681893 (1987-07-01), Roth
J. Med. Chem. 1985, 28, 347-358--G. E. Stokker, et al. "3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase . . . ".
Tetrahedron Letters, vol. 28, No. 13, pp. 1385-1388, 1987 "Synthesis of an HMG-COA Reductase Inhibitor, . . . ".
Daignault Ronald A.
Haley Jacqueline
Lee Mary C.
Warner-Lambert & Company
LandOfFree
[R-(R*R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-( 1-met does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with [R-(R*R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-( 1-met, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [R-(R*R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-( 1-met will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542910